Aurinia Reports First Quarter 2020 Financial Results and Recent Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Aurinia Reports First Quarter 2020 Financial Results and Recent Operational Highlights

Aurinia Pharmaceuticals (AUPH) Reports In-Line Q1 EPS

May 14, 2020 4:34 PM EDT

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q1 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $30 thousand versus the consensus estimate of $50 thousand.

We are fortunate that the global COVID-19 pandemic has had minimal impact on Aurinias operations, and we have maintained our timelines to ensure the filing of the voclosporin NDA by the end of the... More